CD63 and breast carcinoma: For the mouse system, MDA-MB-231 breast cancer cells stably expressing pHluo_M153R-CD63 were injected into the fourth mammary fat pad and observed 7−10 days later by multiphoton imaging through a mammary imaging window (Fig. 4e).